SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000944809-20-000018
Filing Date
2020-05-06
Accepted
2020-05-06 17:18:26
Documents
83
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q opk-3312020x10q.htm   iXBRL 10-Q 1843168
2 EXHIBIT 31.1 opk-3312020xex311.htm EX-31.1 11885
3 EXHIBIT 31.2 opk-3312020xex312.htm EX-31.2 11895
4 EXHIBIT 32.1 opk-3312020xex321.htm EX-32.1 4436
5 EXHIBIT 32.2 opk-3312020xex322.htm EX-32.2 4681
  Complete submission text file 0000944809-20-000018.txt   10177019

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20200331.xsd EX-101.SCH 68450
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20200331_cal.xml EX-101.CAL 109773
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20200331_def.xml EX-101.DEF 401072
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20200331_lab.xml EX-101.LAB 974926
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20200331_pre.xml EX-101.PRE 576013
47 EXTRACTED XBRL INSTANCE DOCUMENT opk-3312020x10q_htm.xml XML 1800247
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 20853656
SIC: 2834 Pharmaceutical Preparations